Vectors for DNA immunization against cervical cancer
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 22, 2001
Issued Date -
N/A
app pub date -
Sep 3, 1999
filing date -
Sep 4, 1998
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Vectors for DNA immunization against cervical cancer comprise a nucleic acid molecule encoding at least one non-toxic T-cell epitope of the E6 and/or E7 antigens of a strain of human papilloma virus (HPV) associated with cervical cancer, such as HPV-16, and a promoter operatively coupled to the nucleic acid molecule for expression of the nucleic acid molecule in a host to which the vector is administered.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully